Abstract: The present invention relates to compounds according to formula (1) and formula (2), said compounds being suitable for use in electronic devices, in particular organic electroluminescent devices.

Abstract: The present invention relates to a polymer which comprises at least one structural unit which contains at least one aldehyde group, and to a process for the preparation of a crosslinkable or crosslinked polymer including a polymer which contains aldehyde groups. The present invention thus also relates to a crosslinkable polymer and a crosslinked polymer which is prepared by the process according to the invention, and to the use of this crosslinked polymer in electronic devices, in particular in organic electroluminescent devices, so-called OLEDs (OLED=organic light emitting device).

Abstract: The invention relates to novel phosphor mixtures comprising three or more silicate phosphors. The invention furthermore relates to the use of these mixtures in electronic and electro-optical devices, in particular in light-emitting diodes (LEDs) for backlighting applications. The invention furthermore relates to LEDs comprising the phosphors.

Abstract: The present invention relates to the use of at least one imidazol derivative of formula I or 1-(3,3,4,4,4-pentafluorobutyl)-1H-imidazole, 1-(3,3,4,4,4-pentafluorobutyl)-1,2,3-triazole or 1-(2?-thioethyl)ethylimidazole as additive in dye-sensitized solar cells and to special electrolyte formulations and a dye-sensitized solar cell comprising at least one compound of formula I or 1-(3,3,4,4,4-pentafluorobutyl)-1H-imidazole, 1-(3,3,4,4,4-pentafluorobutyl)-1,2,3-triazole or 1-(2?-thioethyl)ethylimidazole.

Abstract: The present invention relates to a formulation comprising at least one solvent and at least two functional compounds of the general formula (I) where A is a functional structural element, B is a solubility-promoting structural element and k is an integer in the range from 1 to 20, the molecular weight of the functional compound is at least 550 g/mol and the solubility-promoting structural element B conforms to the general formula (L-I) where Ar1, Ar2 is each, independently of one another, an aryl or heteroaryl group, which may be substituted by one or more radicals R of any desired type, X is in each case, independently of one another, N or CR2, preferably CH, R1, R2 is each, independently of one another, hydrogen, a straight-chain alkyl, alkoxy or thioalkoxy group having 1 to 40 C atoms or a branched or cyclic alkyl, alkoxy or thioalkoxy group having 3 to 40 C atoms or is a silyl group or a substituted keto group having 1 to 40 C atoms, an alkoxycarbonyl group having 2 to 40 C atoms, an aryloxycarbonyl group

Abstract: The present invention is directed to the use of a composite silicon oxide-based material for the modified release of biologically active agents.

Abstract: 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile or a pharmaceutically acceptable salt and/or solvate thereof for the use for the treatment of hepatocellular carcinoma (HCC).

Abstract: A support apparatus for a filter membrane comprises a base support and a disc-shaped porous support member. The member is removably received in a seat portion of the base support in fluid communication with a drain. A bottom side of the disc-shaped porous support member is supported in a support plane. The bottom side of the member is unsupported in an area and the unsupported area is adjacent to a space in the seat portion of the base support that is located and dimensioned such that application of a force, onto the top side of the member at a location substantially within the boundaries of the unsupported area at the bottom side will cause the member to pivot/tilt into the space and lift above the support plane at a diagonally opposite side from the location where the force is applied so that it can be easily grasped and removed.

Abstract: The invention relates to an electro-optical liquid-crystal display having a re-alignment layer for the re-alignment of the liquid crystals whose field has a component, crucial for the re-alignment, parallel to the liquid-crystal layer, containing a liquid-crystalline medium, characterised in that it contains at least one compound of the formula (I), at least one compound of the formula (II), and at least one compound of the formula (III), in which the parameters R11 to R31, X11 and X21 have the meanings indicated in Claim 1.

Abstract: The invention relates to an electro-optical liquid-crystal display having a re-alignment layer for re-alignment of the liquid crystals whose field has a component, crucial for the re-alignment, parallel to the liquid-crystal layer, containing a liquid-crystalline medium, characterised in that it comprises one or more compounds of the formula I1 to I3, (I1) (I2) (I3) and at least one compound of the formula II, in which the parameters R11, R11*, Z0, Sp, k, l, p, Y21 to Y22, R21 and R22 have the meanings indicated in claim 1.

Abstract: This invention relates to colored polymer particles prepared by a reverse emulsion solvent removal process, electrophoretic fluids comprising such particles, and electrophoretic display devices comprising such fluids.

Abstract: The present invention is directed to a continuous affinity chromatography method and to an apparatus to be used in such method. The method allows the use of high operational velocity while maintaining high binding capacities.

Abstract: This invention relates to polymer particles, a process for their preparation, the use of these particles for the preparation of an electrophoretic device, electrophoretic displays comprising such particle, and new polymerisable dyes.

Abstract: The invention relates to a method for screening compounds, which inhibit MetAP2 activity, by providing a cellular system or a sample thereof being capable of expressing MetAP2 and/or EEF1A, incubating at least a portion of the system with compounds to be screened, and detecting MetAP2 inhibition by determining EEF1A with N-terminal methionine residue (MetEEF1A). Another object of the invention concerns a method for monitoring physiological and/or pathological conditions, which are caused, mediated and/or propagated by MetAP2 activity, by administering an effective amount of at least a single compound to a mammal in need of such treatment and determining MetEEF1A in a biological sample withdrawn from the mammal. The invention also relates to the use of EEF1A as biomarker.

Abstract: [Object] To provide a composition for forming a tungsten oxide film from an aqueous solution, and also to provide a pattern formation method employing that composition. [Means] The present invention provides a tungsten oxide film-forming composition comprising: water, a water-soluble metatungstate, and at least one additive selected from the group consisting of anionic polymers, nonionic polymers, anionic surfactants, and tertiary amino group-containing nonionic surfactants. For forming a pattern, this composition can be employed in place of a silicon dioxide film-forming composition in a pattern formation process using an image reversal trilayer structure, a resist undercoat layer or a resist top protective film.

Abstract: The present invention relates to electronic devices comprising organic semiconductors whose content of halogens is less than 20 ppm. This increases the lifetime and the efficiency of the corresponding electronic devices, and these materials are thus better suited to use in organic electronic devices than materials with a higher halogen content. The present invention further relates to corresponding organic semiconductors and to a process for their production.

Abstract: The invention relates to novel polymers containing repeating units based on benzo[2,1,3]thiadiazole-5,6-dicarboxylic acid bis-ester, monomers and methods for their preparation, their use as semiconductors in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices, and to OE and OPV devices comprising these polymers.

Abstract: The present invention relates to solid formulations which contain at least one porous carrier and one or more functional substances in a stable mixture, and to the use thereof.

Abstract: The invention generally relates to passivation layers for use in organic electronic devices, and more specifically in organic field effect transistors, to processes for preparing such passivation layers, and to organic electronic devices and organic field effect transistors encompassing such passivation layers.

Abstract: The present invention relates to metal complexes and electronic devices, in particular organic electroluminescent devices such as OLEDs, containing said metal complexes. The following compounds of formula (1) are claimed: M(L)n(L?)m, the compound of general formula (1) containing a sub-structure M(L)n of formula (2) and L representing a mono-anionic ligand. Formula (2). The variables are defined as follows: M represents Cu, Ag, Au, Ru, Zn, Al, Ga or In; A represents a co-ordinating group which co-ordinates with M and can be substituted with one or more substituents R; the other variables are defined as cited in the claims.